medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2020-18-32-41medsovet-5891Research ArticleБРОНХОПУЛЬМОНОЛОГИЯ. ЛОРBRONCHOPULMONOLOGY. ENTБиорегуляционная терапия в лечении и профилактике заболеваний верхних дыхательных путей у детейBioregulatory therapy in the treatment and prevention of upper respiratory tract diseases in childrenhttps://orcid.org/0000-0002-5024-6135ГаращенкоТ. И.GarashchenkoT. I.

д.м.н., профессор, ученый секретарь; профессор кафедры оториноларингологии факультета дополнительного профессионального образования

123182, Россия, Москва, Волоколамское шоссе, д. 30, корп. 2

117997, Россия, Москва, ул. Островитянова, д. 1

Dr. of Sci. (Med.), Professor, Scientific Secretary; Professor of the Department of Otorhinolaryngology Faculty of Additional Professional Education 

30, Bldg. 2, Volokolamskoe Shosse, Moscow, 123182, Russia

1, Ostrovityanov St., Moscow, 117997, Russia

9040100@mail.ruhttps://orcid.org/0000-0002-8534-8932СельковаЕ. П.SelkovaE. P.

Dr. of Sci. (Med.), Professor, Head of the Laboratory of Diagnostics and Prevention of Infectious Diseases, Chief Researcher

10, Admiral Makarov St., Moscow, 125212, Russia

selkova.e@mail.ruhttps://orcid.org/0000-0002-5721-1699КарнееваО. В.KarneevaO. V.

123182, Россия, Москва, Волоколамское шоссе, д. 30, корп. 2

117997, Россия, Москва, ул. Островитянова, д. 1 

Dr. of Sci. (Med.), Professor, Scientific Secretary; Professor of the Department of Otorhinolaryngology Faculty of Additional Professional Education

30, Bldg. 2, Volokolamskoe Shosse, Moscow, 123182, Russia

1, Ostrovityanov St., Moscow, 117997, Russia

karneeva@yandex.ruГаращенкоМ. В.GarashchenkoM. V.

к.м.н., председатель комитета

180001, Россия, Псков, ул. Некрасова, д. 23

Cand. of Sci. (Med.), Chairman 

23, Nekrasov St., Pskov, 180001, Russia

mv.garashenko@zdrav.pskov.ruhttps://orcid.org/0000-0002-9038-3687ОганесянА. С.OganesyanA. S.

научный сотрудник лаборатории диагностики и профилактики инфекционных заболеваний

125212, Россия, Москва, ул. Адмирала Макарова, д. 10

Researcher, Laboratory of Diagnosis and Prevention of Infectious Diseases

10, Admiral Makarov St., Moscow, 125212, Russia

arpinka85@mail.ruНациональный медицинский исследовательский центр оториноларингологии; Российский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияFederal State Budgetary Institution “Scientific and Clinical Center of Otorhinolaryngology of the Federal Medico-Biological Agency of the Russian Federation”; Federal State Autonomous Educational Institution of Higher Education “Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian FederationRussian FederationФедеральное бюджетное учреждение науки «Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаРоссияG.N. Gabrichevsky research institute for Epidemiology and MicrobiologyRussian FederationКомитет по здравоохранению Псковской областиРоссияHealthcare of the Pskov RegionRussian FederationФедеральное бюджетное учреждение науки «Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаРоссияG.N. Gabrichevsky research institute for Epidemiology and MicrobiologyRussian Federation2020251120200183241Copyright © Гаращенко Т.И., Селькова Е.П., Карнеева О.В., Гаращенко М.В., Оганесян А.С., 20202020Гаращенко Т.И., Селькова Е.П., Карнеева О.В., Гаращенко М.В., Оганесян А.С.Garashchenko T.I., Selkova E.P., Karneeva O.V., Garashchenko M.V., Oganesyan A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/5891острая респираторная вирусная инфекциягрипппрофилактикалечениеаcute respiratory viral infectionflupreventiontherapyReferencesАнготоева И.Б. Острые респираторные инфекции. Взгляд отоларинголога. Медицинский совет. 2013;(4-2):16–23. doi: 10.21518/2079-701X-2013-4-2-16-23.Angotoyeva I.B. Acute respiratory infections: an otorhinolaryngologist’s view. Meditsinskiy sovet = Medical Council. 2013;(4-2):16–23. (In Russ.) doi: 10.21518/2079-701X-2013-4-2-16-23.Соловьев М.Ю., Ковалев Е.В., Ненадская С.А., Кадыкова Л.Е. Эпидемиологические особенности гриппа и ОРВИ в сезон 2009—2010 гг., меры профилактики на территории Ростовской области. Главный врач Юга России. 2011;(1):7–8. Режим доступа: https://cyberleninka.ru/article/n/epidemiologicheskie-osobennosti-grippa-i-orvi-v-sezon-2009-2010-gg-mery-profilaktiki-na-territorii-rostovskoy-oblasti.Solov’ev M.Yu., Kovalev E.V., Nenadskaya S.A., Kadykova L.E. Epidemiological features of influenza and ARVI in the 2009–2010 season, preventive measures in the Rostov region. Glavnyy vrach Yuga Rossii = Chief Physician of the South of Russia. 2011;(1):7–8. (In Russ.) Available at: https://cyberleninka.ru/article/n/epidemiologicheskie-osobennostigrippa-i-orvi-v-sezon-2009-2010-gg-mery-profilaktiki-na-territorii-rostovskoy-oblasti.Холодова И.Н., Сырьева Т.Н., Холодов Д.И. Профилактика и лечение ОРИ – комплексный подход. Медицинский совет. 2019;(2):61–67. doi: 10.21518/2079-701X-2019-2-61-67.Kholodova I.N., Syrieva T.N., Kholodov D.I. An integrated approach to the prevention and treatment of ARI. Meditsinskiy sovet = Medical Council. 2019;(2):61–67. (In Russ.) doi: 10.21518/2079-701X-2019-2-61-67.Ершов Ф.И. Рациональная фармакотерапия гриппа и ОРВИ. Фармацевтический вестник. 2003;33(312).Ershov F.I. Rational pharmacotherapy of influenza and ARVI. Farmatsevticheskiy vestnik = Pharmaceutical Bulletin. 2003;33(312). (In Russ.)Gottwald R., Weiser M. Antihomotoxic Treatment of Agitation with and without Fever in Children. Results of postmarketing clinical study. Biomed Med. 1999;28(6):308–312. Available at: http://www.biopathica.co.uk/Articles/General%20Items/36%20-%20Antihomotoxic%20Treatment%20of%20Agitation%20with%20and%20without%20F.pdf.Gottwald R., Weiser M. Antihomotoxic Treatment of Agitation with and without Fever in Children. Results of postmarketing clinical study. Biomed Med. 1999;28(6):308–312. Available at: http://www.biopathica.co.uk/Articles/General%20Items/36%20-%20Antihomotoxic%20Treatment%20of%20Agitation%20with%20and%20without%20F.pdf.Калюжин О.В. Острые респираторные вирусные инфекции: современные вызовы, противовирусный ответ, иммунопрофилактика и иммунотерапия. М.: Медицинское информационное агентство; 2014. 144 с. Режим доступа: https://piratebooks.ru/threads/ostrie-respiratornie-virusnieinfekcii-sovremennie-vizovi-protivovirusniy-otvet-immunoprofilaktika-iimmunoterapiya.250209.Kalyuzhin O.V. Acute respiratory viral infections: modern challenges, antiviral response, immunoprophylaxis and immunotherapy. Moscow: Medical news agency; 2014. 144 p. (In Russ.) Available at: https://piratebooks.ru/threads/ostrie-respiratornie-virusnie-infekcii-sovremennie-vizovi-protivovirusniyotvet-immunoprofilaktika-i-immunoterapiya.250209.Геппе Н.А., Малахов А.Б. (ред.). Комплексный подход к лечению и профилактике острых респираторных вирусных инфекций у детей: Практическое руководство для врачей. М.; 2012. 47 с.Geppe N.A., Malakhov A.B. (eds.). An Integrated Approach to the Treatment and Prevention of Acute Respiratory Viral Infections in Children: A Practical Guide for Physicians. Moscow; 2012. 47 p. (In Russ.)Mahony J.B. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev. 2008;21(4):716–747. doi: 10.1128/CMR.00037-07.Mahony J.B. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev. 2008;21(4):716–747. doi: 10.1128/CMR.00037-07.Бургасова О.А., Краева Л.А., Петрова И.С., Келли Е.И. Случай тяжелого течения смешанной респираторно-вирусной инфекции (грипп А (H1N1) + RS-вирусная), осложненной внебольничной пневмонией, вызванной Streptococcus equi. Инфекционные болезни. 2015;13(1):71–74. Режим доступа: https://elibrary.ru/item.asp?id=23405273.Burgasova O.A., Kraeva L.A., Petrova I.S., Kelly E.I. A Severe case of mixed respiratory viral infection (influenza A(H1n1) + Rs virus), complicated by community-acquired pneumonia caused by streptococcus equi. Infektsionnye bolezni = Infectious Diseases. 2015;13(1):71–74. (In Russ.) Available at: https://elibrary.ru/item.asp?id=23405273.Beale J., Jayaraman A., Jackson D.J., Macintyre J.D.R., Edwards M.R., Walton R.P. et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Trans Med. 2014;6(256):256ra134. doi: 10.1126/scitranslmed.3009124.Beale J., Jayaraman A., Jackson D.J., Macintyre J.D.R., Edwards M.R., Walton R.P. et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Trans Med. 2014;6(256):256ra134. doi: 10.1126/scitranslmed.3009124.Киселев О.И., Цыбалова Л.М., Покровский В.И. (ред.). Грипп: эпидемиология, диагностика, лечение, профилактика. М.: Медицинское информационное агентство; 2012. 496 с.Kiselev O.I., Tsybalova L.M., Pokrovskiy V.I. (eds.) Influenza: epidemiology, diagnosis, treatment, prevention. Moscow: Meditsinskoe informatsionnoe agentstvo; 2012. 496 р. (In Russ.)Madjid M., Curkendall S., Blumentals W.A. Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection. Cardiology. 2009;113(2):98–107. doi: 10.1159/000172796.Madjid M., Curkendall S., Blumentals W.A. Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection. Cardiology. 2009;113(2):98–107. doi: 10.1159/000172796.Gwaltney J.M. Jr. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23(6):1209–1223. doi: 10.1093/clinids/23.6.1209.Gwaltney J.M. Jr. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23(6):1209–1223. doi: 10.1093/clinids/23.6.1209.Гаращенко Т.И., Гаращенко М.В., Мезенцева М.В. Клинико- иммунологическое обоснование гомеопатических препаратов в профилактике и лечении гриппа и ОРВИ. РМЖ. 2005;(21):1432. Режим доступа: https://www.rmj.ru/articles/obshchie-stati/Klinikoimmunologicheskoe_obosnovanie_gomeopaticheskih_preparatov_v_profilaktike_i_lechenii_grippa_i_ORVI.Garashchenko T.I., Garashchenko M.V., Mezentseva M.V. Clinical and immunological substantiation of homeopathic medicines in the prevention and treatment of influenza and ARVI. RMZH = RMJ. 2005;(21):1432. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Klinikoimmunologicheskoe_obosnovanie_gomeopaticheskih_preparatov_v_profilaktike_i_lechenii_grippa_i_ORVI.Гаращенко Т.И., Мезенцева М.В., Ильенко Л.И., Гаращенко М.В. Клинико-иммунологическое обоснование применения Афлубина в профилактике и лечении вирусных заболеваний респираторного тракта у детей. Детские инфекции. 2005;4(3):49–53. Режим доступа: https://cyberleninka.ru/article/n/kliniko-immunologicheskoe-obosnovanieprimeneniya-aflubina-v-profilaktike-i-lechenii-virusnyh-zabolevaniyrespiratornogo-trakta-u.Garashchenko T.I., Mezentseva M.V., Il’enko L.I., Garashchenko M.V. Clinical and immunological rationale for the use of Aflubin in the prevention and treatment of viral diseases of the respiratory tract in children. Detskie infektsii = Children Infections. 2005;4(3):49–53. (In Russ.) Available at:Еропкин М.Ю., Гудкова Т.М., Даниленко Д.М., Коновалова Н.И., Григорьева В.И., Смирнова Т.С. и др. Пандемический грипп 2009 г. в России: происхождение, антигенные, биологические свойства вируса и чувствительность к противовирусным препаратам. РМЖ. 2010;(7):410. Режим доступа: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/https://cyberleninka.ru/article/n/kliniko-immunologicheskoe-obosnovanie-primeneniya-aflubina-v-profilaktike-i-lechenii-virusnyh-zabolevaniy-respiratornogo-trakta-u.Pandemicheskiy_gripp_2009_g_v_Rossii__proishoghdenie_antigennye_biologicheskie__svoystva_virusa_i_chuvstvitelynosty__k_protivovirusnym_preparatam/#ixzz6bVGnxCVy.Eropkin M.Yu., Gudkova T.M., Danilenko D.M., Konovalova N.I., Grigor’eva V.I., Smirnova T.S. et al. RMZH = RMJ. 2010;(7):410. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Pandemicheskiy_gripp_2009_g_v_Rossii__proishoghdenie_antigennye_biologicheskie__svoystva_virusa_i_chuvstvitelynosty__k_protivovirusnym_preparatam/#ixzz6bVGnxCVy.Wagner H., Jurcic K., Doenicke A., Behrens N. Influence of homeopathic drug preparations on the phagocytosis capability of granulocytes. Biol Ther. 1986;XI(2):43–49.Wagner H., Jurcic K., Doenicke A., Behrens N. Influence of homeopathic drug preparations on the phagocytosis capability of granulocytes. Biol Ther. 1986;XI(2):43–49.Wagner H. Examination of the immune-stimulation effect of some plant homeopathic drugs. Biol Ther. 1986;IV(2):21–27. Available at: http://www.biopathica.co.uk/Articles/Immune%20System/1%20-%20Examination%20of%20the%20Immune%20Stimulation%20Effect%20of%20some%20Pla.pdf.Wagner H. Examination of the immune-stimulation effect of some plant homeopathic drugs. Biol Ther. 1986;IV(2):21–27. Available at: http://www.biopathica.co.uk/Articles/Immune%20System/1%20-%20Examination%20of%20the%20Immune%20Stimulation%20Effect%20of%20some%20Pla.pdf.Enbergs H. Effects of the homeopathic preparation Engystol® on interferon-g production by human T-lymphocytes. Immunol Invest. 2006;35(1):19–27. doi: 10.1080/08820130500496753.Enbergs H. Effects of the homeopathic preparation Engystol® on interferon-g production by human T-lymphocytes. Immunol Invest. 2006;35(1):19–27. doi: 10.1080/08820130500496753.Torbicka E., Brzozowska-Binda A., Wilczynski J., Uzerowicz A. RSV Infections in Infants: Therapy with a Homeopathic Preparation. Biomed Ther. 1998;XVI(4):256–260. Available at: http://www.biopathica.co.uk/Articles/General%20Items/22%20-%20RSV%20Infections%20in%20Infants%20-%20Therapy%20with%20a%20Homeopathic%20.pdf.Torbicka E., Brzozowska-Binda A., Wilczynski J., Uzerowicz A. RSV Infections in Infants: Therapy with a Homeopathic Preparation. Biomed Ther. 1998;XVI(4):256–260. Available at: http://www.biopathica.co.uk/Articles/General%20Items/22%20-%20RSV%20Infections%20in%20Infants%20-%20Therapy%20with%20a%20Homeopathic%20.pdf.Wronski S., Dannenmaier J., Schild S., Macke O., Müller L., Burmeister Y. et al. Engystol reduces onset of experimental respiratory syncytial virusinduced respiratory inflammation in mice by modulating macrophage phagocytic capacity. PLoS One. 2018;13(4):e0195822. doi: 10.1371/journal.pone.0195822.Wronski S., Dannenmaier J., Schild S., Macke O., Müller L., Burmeister Y. et al. Engystol reduces onset of experimental respiratory syncytial virusinduced respiratory inflammation in mice by modulating macrophage phagocytic capacity. PLoS One. 2018;13(4):e0195822. doi: 10.1371/journal.pone.0195822.Denys A., Siewierska K. Efficacy of preoperative immunoprophylaxis in patients with neoplastic diseases (II). Estimation of antihaemagglutinin and antineuraminidase antibody titre or influenza viruses A and B Int Rev Allergol Clin Immunol. 1999;5(1):46–50. Available at: http://www.biopathica.co.uk/Articles/Degenerative%20Diseases/21%20-%20Efficacy%20of%20Preoperative%20Immunoprophylaxis%20in%20Patients%20with%20Neoplastic%20Diseases.pdf.Denys A., Siewierska K. Efficacy of preoperative immunoprophylaxis in patients with neoplastic diseases (II). Estimation of antihaemagglutinin and antineuraminidase antibody titre or influenza viruses A and B Int Rev Allergol Clin Immunol. 1999;5(1):46–50. Available at: http://www.biopathica.co.uk/Articles/Degenerative%20Diseases/21%20-%20Efficacy%20of%20Preoperative%20Immunoprophylaxis%20in%20Patients%20with%20Neoplastic%20Diseases.pdf.Siewierska K., Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic diseases (I). Int Rev Allergol Clin Immunol. 1999;5(1):39–45.Siewierska K., Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic diseases (I). Int Rev Allergol Clin Immunol. 1999;5(1):39–45.Roeska K., Seilheimer B. Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment. J Immune Based Ther Vaccines. 2010;8:6. doi: 10.1186/1476-8518-8-6.Roeska K., Seilheimer B. Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment. J Immune Based Ther Vaccines. 2010;8:6. doi: 10.1186/1476-8518-8-6.Herzberger G., Weiser M. Homeopathic Treatment of Infections of Various Origins: A Prospective Study. Biomed Ther. 1997;XV(4):123–127. Available at: http://www.biopathica.co.uk/Articles/General%20Items/94%20-%20Herzberger G., Weiser M. Homeopathic Treatment of Infections of Various Origins: A Prospective Study. Biomed Ther. 1997;XV(4):123–127. Available at: http://www.biopathica.co.uk/Articles/General%20Items/94%20-%20Homeopathic%20Treatment%20of%20Infections%20of%20Various%20Origins.pdf.Homeopathic%20Treatment%20of%20Infections%20of%20Various%20Origins.pdf.Schmiedel V., Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: an observational study. Explore. 2006;2(2):109–114. doi: 10.1016/j.explore.2005.12.008.Schmiedel V., Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: an observational study. Explore. 2006;2(2):109–114. doi: 10.1016/j.explore.2005.12.008.Matusiewicz R. The effect of a homeopathic preparation on the clinical condition of patients with corticosteroiddependent bronchial asthma. Biomed Ther. 1997;XV(3):7074.Matusiewicz R. The effect of a homeopathic preparation on the clinical condition of patients with corticosteroiddependent bronchial asthma. Biomed Ther. 1997;XV(3):7074.Heilmann A. A combination injection preparation as a prophylactic for flu and common colds. Biol Ther. 1994;VII(4):249–253. Available at: http://www.biopathica.co.uk/Articles/Colds%20and%20Flu/2%20-%20A%20Combination%20Injection%20Preparation%20as%20a%20Prophylactic%20fo.pdf.Heilmann A. A combination injection preparation as a prophylactic for flu and common colds. Biol Ther. 1994;VII(4):249–253. Available at: http://www.biopathica.co.uk/Articles/Colds%20and%20Flu/2%20-%20Fimiani V., Cavallaro A., Ainis O., Bottari C. Immunomodulatory effect of the homoeopathic drug Engystol-N on some activities of isolated human leukocytes and in whole blood. Immunopharmacol Immunotoxicol. 2000;22(1):103–115. doi: 10.3109/08923970009016409.A%20Combination%20Injection%20Preparation%20as%20a%20Prophylactic%20fo.pdf.Wagner H., Jurcic K. Immunological studies of plant-extract combinations – invitro and invivo studies on the stimulation of phagocytosis. Arzneimittel­Forschung. 1991;41(2):1072–1076. (In German) Available at: https://europepmc.org/article/med/1799388.Fimiani V., Cavallaro A., Ainis O., Bottari C. Immunomodulatory effect of the homoeopathic drug Engystol-N on some activities of isolated human leukocytes and in whole blood. Immunopharmacol Immunotoxicol. 2000;22(1):103–115. doi: 10.3109/08923970009016409.Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(S29):1–464. doi: 10.4193/Rhin20.600.Wagner H., Jurcic K. Immunological studies of plant-extract combinations – invitro and invivo studies on the stimulation of phagocytosis. Arzneimittel­Forschung. 1991;41(2):1072–1076. (In German) Available at: https://europepmc.org/article/med/1799388.Ryazantsev S.V. (ed.). Principles of etiopathogenetic therapy of acute rhinosinusitis: guidelines. St Petersburg: Poliforum Grupp; 2014. 40 p. (In Russ.)Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(S29):1–464. doi: 10.4193/Rhin20.600.Zenner S., Metelmann H. Empirical data on therapy with a homeopathic nasal spray. Hufeland J. 1992. Available at: http://www.biopathica.co.uk/documents/clinical%20trials/Empirical%20Data%20on%20Nasal%20Spray.pdf.Рязанцев С.В. (ред.). Принципы этиопатогенетической терапии острых риносинуситов: методические рекомендации. СПб.: Полифорум Групп; 2014. 40 с.Weiser M., Clasen B.P.E. Randomisierte plazebokontrollierte doppelblindstudie zur untersuchung der klinischen wirksamkeit der homöopathischen euphorbium compositum-nasen-tropfen s bei chronischer sinusitis. Forsch Komplementärmed. 1994;1:251–259. doi: 10.1159/000209924.Zenner S., Metelmann H. Empirical data on therapy with a homeopathic nasal spray. Hufeland J. 1992. Available at: http://www.biopathica.co.uk/documents/clinical%20trials/Empirical%20Data%20on%20Nasal%20Spray.pdf.Sprenger F. The therapy of rhinitis. Biol Ther. 1989;7(3):60–63. Available at: http://www.biopathica.co.uk/Articles/Hay%20Fever%20and%20Rhinitis/1%20-%20The%20Therapy%20of%20Rhinitis.pdf.Weiser M., Clasen B.P.E. Randomisierte plazebokontrollierte doppelblindstudie zur untersuchung der klinischen wirksamkeit der homöopathischen euphorbium compositum-nasen-tropfen s bei chronischer sinusitis. Forsch Komplementärmed. 1994;1:251–259. doi: 10.1159/000209924.Connert W.D., Maiwald J. The therapy of rhinopathy: results of application of a biotherapeutic nasal spray. Biol Ther. 1991;9(4):182–192.Sprenger F. The therapy of rhinitis. Biol Ther. 1989;7(3):60–63. Available at: http://www.biopathica.co.uk/Articles/Hay%20Fever%20and%20Rhinitis/1%20-%20The%20Therapy%20of%20Rhinitis.pdf.Ammerschläger H., Klein P., Weiser M., Oberbaum M. Treatment of inflammatory diseases of the upper respiratory tract – comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementarmed Klass Naturheilkd. 2005;12(1):24–31. (In German). doi: 10.1159/000082934.Connert W.D., Maiwald J. The therapy of rhinopathy: results of application of a biotherapeutic nasal spray. Biol Ther. 1991;9(4):182–192.Raab V. Further therapy experience with Euphorbium compositum nasal drops (metered-dose spray without propellant gas) in the ENT specialist practice. Biologische Medizin. 1982;11(4):176–179. (In German).Ammerschläger H., Klein P., Weiser M., Oberbaum M. Treatment of inflammatory diseases of the upper respiratory tract – comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementarmed Klass Naturheilkd. 2005;12(1):24–31. (In German). doi: 10.1159/000082934.Gottwald R., Weiser M. Antihomotoxic treatment of chronic sinusitis: Results of a drug monitoring study with Euphorbium compositum S Drops. Medicina Biológica. 2000;13(3):84–87. Available at: http://www.biopathica.co.uk/Articles/General%20Items/27%20-%20Antihomotoxic%20Treatment%20of%20Chronic%20Sinusitis.pdf.Raab V. Further therapy experience with Euphorbium compositum nasal drops (metered-dose spray without propellant gas) in the ENT specialist practice. Biologische Medizin. 1982;11(4):176–179. (In German).Urlea-Schön I., Corgiolu M. Effectiveness and tolerability of Euphorbium compositum SN for the symptomatic treatment of rhinitis in children aged 2–6 years. Eur J Integr Med. 2009;1(4):236. doi: 10.1016/j.eujim.2009.08.026.Gottwald R., Weiser M. Antihomotoxic treatment of chronic sinusitis: Results of a drug monitoring study with Euphorbium compositum S Drops. Medicina Biológica. 2000;13(3):84–87. Available at: http://www.biopathica.co.uk/Articles/General%20Items/27%20-%20Antihomotoxic%20Treatment%20of%20Chronic%20Sinusitis.pdf.Glatthaar-Saalmüller B., Borner M., Weiser M. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin. 2002;31(4):194–195. (In German) Available at: https://www.researchgate.net/publication/289884844_Euphorbium_compositum_Viruses_of_upper_Urlea-Schön I., Corgiolu M. Effectiveness and tolerability of Euphorbium compositum SN for the symptomatic treatment of rhinitis in children aged 2–6 years. Eur J Integr Med. 2009;1(4):236. doi: 10.1016/j.eujim.2009.08.026.respiratory_tract_inhibited.Glatthaar-Saalmüller B., Borner M., Weiser M. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin. 2002;31(4):194–195. (In German) Available at: https://www.researchgate.net/publication/289884844_Euphorbium_compositum_Viruses_of_upper_respiratory_tract_inhibited.Glatthaar-Saalmüller B., Fallier-Becker P. Antiviral action of Euphorbium compositum and its components. Forsch Komplementarmed Klass Naturheilkd. 2001;8(4):207–212. doi: 10.1159/000057223.Glatthaar-Saalmüller B., Fallier-Becker P. Antiviral action of Euphorbium compositum and its components. Forsch Komplementarmed Klass Naturheilkd. 2001;8(4):207–212. doi: 10.1159/000057223.Metelmann H., Glatthaar-Saalmüller B. Antiviral action of a homeopathic medication. Biomed Ther. 2000;18(1):160–164. Available at: http://www.biopathica.co.uk/Articles/Clinical%20Trials/2%20-%20Antiviral%20Action%20of%20a%20Homeopathic%20Medication.pdf.Metelmann H., Glatthaar-Saalmüller B. Antiviral action of a homeopathic medication. Biomed Ther. 2000;18(1):160–164. Available at: http://www.biopathica.co.uk/Articles/Clinical%20Trials/2%20-%20Antiviral%20Action%20of%20a%20Homeopathic%20Medication.pdf.Schmolz M., Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biologische Medizin. 1998;155–158. Available at: http://www.biopathica.co.uk/documents/clinical%20trials/Modulation%20of%20Cytokine%20Synthesis.pdf.Schmolz M., Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biologische Medizin. 1998;155–158. Available at: http://www.biopathica.co.uk/documents/clinical%20trials/Modulation%20of%20Cytokine%20Synthesis.pdf.Glatthaar-Saalmller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel® on selected respiratory viruses. Can J Physiol Pharmacol. 2007;85(11):1084–1090. doi: 10.1139/Y07-100.Glatthaar-Saalmller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel® on selected respiratory viruses. Can J Physiol Pharmacol. 2007;85(11):1084–1090. doi: 10.1139/Y07-100.Maiwaid L., Weinfurtner T., Mau J., Connart W.D. Therapy of Common Cold with a Homeopathic Combination Preparation in Comparison with Acetylsalicylic Acid. A Controlled, Randomized Single-blind Study. Arzneimittelforschiaig. 1988;38(4):578–582. (In German) Available at: https://pubmed.ncbi.nlm.nih.gov/3041973.Maiwaid L., Weinfurtner T., Mau J., Connart W.D. Therapy of Common Cold with a Homeopathic Combination Preparation in Comparison with Acetylsalicylic Acid. A Controlled, Randomized Single-blind Study. Arzneimittelforschiaig. 1988;38(4):578–582. (In German) Available at: https://pubmed.ncbi.nlm.nih.gov/3041973.Rabe A., Weiser M., Klein P. Effectiveness and tolerability of a homeopathic remedy compared with conventional therapy for mild viral infections. Int J Clin Pract. 2004;58(9):827–832. doi: 10.1111/j.1742-1241.2004.00150.x.Rabe A., Weiser M., Klein P. Effectiveness and tolerability of a homeopathic remedy compared with conventional therapy for mild viral infections. Int J Clin Pract. 2004;58(9):827–832. doi: 10.1111/j.1742-1241.2004.00150.x.Weiser M., Gottwald R. Therapie von Grippe und grippalen Infekten mit einem Homoopathikum. Natura Med. 2000;15(1):15–18.Weiser M., Gottwald R. Therapie von Grippe und grippalen Infekten mit einem Homoopathikum. Natura Med. 2000;15(1):15–18.Gottwald R., Weiser M. Homöopathische Behandlung von grippalen Infekten bei Kindern. Ärztezeitschrift für Natuiheilvarfahren. 2000;41(6):346–351.Gottwald R., Weiser M. Homöopathische Behandlung von grippalen Infekten bei Kindern. Ärztezeitschrift für Natuiheilvarfahren. 2000;41(6):346–351.Rabe A. Symptomatische Behandlung akuter grippaler Infekte: Homöopathikum und konventionelle Therapie im Vergleich. Der Allgemeinarzt. 2003;25(20):1522–1523.Rabe A. Symptomatische Behandlung akuter grippaler Infekte: Homöopathikum und konventionelle Therapie im Vergleich. Der Allgemeinarzt. 2003;25(20):1522–1523.Wagner H., Jurric K., Doentcka A., Rosenhuber E., Behrens N. Effect of homeopathic drugs on the phagocytic activity of human granulocytes. In vitro tests in a controlled single-blind study. Arzneimittel­forschung. 1986;36(9):1421–1425. (In German) Available at: https://europepmc.org/article/med/3539129.Wagner H., Jurric K., Doentcka A., Rosenhuber E., Behrens N. Effect of homeopathic drugs on the phagocytic activity of human granulocytes. In vitro tests in a controlled single-blind study. Arzneimittel­forschung. 1986;36(9):1421–1425. (In German) Available at: https://europepmc.org/article/med/3539129.Il’enko L.I., Garashchenko T.I. Non­specific prevention of influenza and ARVI in epidemic and interepidemic periods in organized children’s groups. Guidelines. Мoscow; 2007. 60 p. (In Russ.)Ильенко Л.И., Гаращенко Т.И. Неспецифическая профилактика гриппа и ОРВИ в эпидемический и межэпидемический периоды в организованных детских коллективах. Методические рекомендации. М.; 2007. 60 с.Ильенко Л.И., Гаращенко Т.И. Неспецифическая профилактика гриппа и ОРВИ в эпидемический и межэпидемический периоды в организованных детских коллективах. Методические рекомендации. М.; 2007. 60 с.

The authors declare that there are no conflicts of interest present.